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THE CUTANEOUS GLUCOSE TOLERANCE TEST
I. A RATE CONSTANT FORMULA FOR GLUCOSE DISAPPEARANCE FROM THE SKIN*
RAMON M. FUSARO, M.D., M.S., JOHN A. JOHNSON AND JOHN VAN PILSUM, Pi.D.
The concept of a cutaneous glucose tolerance
test has been reported several times (1—4). It seems
reasonable to assume that skin, like blood, can
dispose of an extracellular carbohydrate load in an
orderly manner. TJrbach, et at (2—4) described a
cutaneous glucose tolerance technic which they
used to study the ability of the skin to deal with a
sudden glucose load after a fasting patient was
given 100 gm of dextrose orally. If the fasting skin
sugar level was above 68 mg%, the patient was
considered abnormal. If the blood glucose toler-
ance test was normal and the skin glucose value
was abnormal, the patient had "skin diabetes"
or "hyperglycodermia without hyperglycemia."
TJrbach's concept of a cutaneous glucose toler-
ance test appeared to be reasonable, but the
analysis of their data was unreliable because of a
number of undeterminable variables in their
technic. Since the dextrose is given orally, the
same variables which affect the blood glucose
tolerance test also affect the cutaneous glucose
tolerance test.
The variables in the blood glucose tolerance test
following oral ingestion of dextrose have been
discussed by several authors (5—7). The major
source of error is that the dextrose is introduced
to the body orally. It has been shown (5, 6) that
variable amounts (as much as 70%) of orally
administered dextrose may remain in the stomach
up to two hours after the start of the test; there-
fore, glucose enters the blood at an unknown rate
and consequently the blood glucose levels are
dependent upon this variable factor.
Another undetermined variable in the oral
glucose tolerance test is the effect of the liver on
the glucose absorbed from the gastrointestinal
tract. Scow and Cornfield (8) have shown that in
rats 67% of the portal vein glucose was retained
in the liver, and 33% entered the general systemic
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circulation. Of the 67% which was retained by the
liver, approximately 37% (25% of the total dex-
trose given) was converted to glycogen and the
fate of the remainder (42% of the total) was
unknown. Since the administration of dextrose
intravenously rather than orally eliminates both
these variables, we investigated the use of the
intravenous glucose tolerance technic.
Amatuzio, et at (5) have shown that if glucose
is given intravenously over a four minute period
to a human subject, the plots of excess glucose
values against time (in minutes) on rectangular
graph paper exhibit an exponential curve. The
rate of disappearance of excess glucose from the
blood is best represented by the following equa-
tion:
Ct = equation (I)t
In view of the inadequacies of the oral glucose
tolerance test the technic of intravenous injection
of dextrose was used in order to develop a reliable
method for evaluating the disappearance of glu-
cose from the skin.
METHOD5 AND TECHNIC
The individuals to be tested fasted overnight.
Triplicate specimens of blood were obtained the
next morning by the finger prick method and trip-
licate specimens of whole skin (connective tissue
plus epidermis) were removed by cutaneous biopsy
punch prior to the intravenous administration of
dextrose. Six to eight blood and skin specimens
were then taken at recorded intervals after injec-
tion. The technic for the extraction and determi-
nation of extracellular glucose ha been described
previously (9).
RESULTS AND DI5CtTSSION
We confirmed what previous investigators
(5—7) have found for the blood glucose tolerance
test done by the intravenous method; that is,
plots of excess mg % blood glucose versus time
showed straight lines on semilogarithmic graphs.
Because a specific enzymatic method for deter-
mining glucose was used, whereas the earlier
f The reader is referred to Amatuzio, et al (5)
for complete definition of the equation.
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studies employed less specific chemical methods,
and since exponential curves were obtained, the
observation (5) was verified that other reducing
substances in the blood do not fluctuate during
the test.
Upon plotting excess mg % skin glucose versus
time a geometric curve was obtained on co-
ordinate graph paper. This curve was exponential
in the time interval of 35 to 65 minutes after the
start of the intravenous injection of dextrose. A
typical curve is illustrated in Figure 1. Several
experiments established that skin glucose content
does not reach a maximum concentration until
approximately 30 minutes after the injection of
dextrose; excess mg % glucose values at shorter
time intervals represent a state of non-equilibrium
which cannot be represented by the first-order
kinetic expression, equation (I). On the assump-
tion that the exponential section of the skin
glucose curve represented the same type of
phenomenon as the disappearance of glucose from
blood, the excess mg % skin glucose values were
plotted on semilogarithmic graph paper. A
straight line was obtained using the method of
least squares and represented points lying within
the above-mentioned time interval of 35-65
minutes. A typical plot is illustrated by Figure 2.
Thus, it appears that after intravenous injection
of dextrose the rate of disappearance of glucose
from whole skin is constant over a limited time
interval (35—65 minutes) and can be expressed by
the formula:
S0e equation (II)
TABLE 1
Glucose di8appearance rate constants
in blood and skin
Skin Glucose Concentrotion In mg%
(wet weight)On Coordinate Graph
Paper
Peak approximately at
,.3Oto35mlnutes
Individuals
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Blood: % per mm.
2.7
1.5
2.7
1.4
0.8
2.2
1.3
1.4
0.2
3.0
2.2
1.7
2.4
2.7
1.0
1.7
3.0
1.5
2.9
1.8
2.0
1.8
2.3
2.5
1.9
2.1
1.9
2.2
2.2
2.8
Time (in minutes)
FIG. 1
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0.3
1.7
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0.7
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0.3
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0.5
2.0
1.2
0.8
1.9
3.2
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SKIN GLUCOSE 361
where:
= the glucose excess* in mg per 100 gm of
whole skin (wet weight) at time (t)
between the time interval of 35 to 65
minutes.
= the glucose excess* in mg per 100 gm of
whole skin (wet weight) extrapolated to
time zero. This is not a physiological
value but represents a useful mathe-
matical expression for determining the
slope of the straight line curve described
by the experimental data.
and:
= the rate of disappearance of glucose from
the skin (expressed in % per minute).
SUMMARY
Using the intravenous technic, the cutaneous
glucose tolerance test has been performed on
thirty individuals. Plots of excess skin glucose
(on logarithmic scale) versus time (on linear
scale) yielded straight lines. At least six to eight
post-injection specimens of skin were taken be-
cause an occasional specimen was not consistent
in its glucose value when compared with the
majority of the specimens. The reason for these
inconsistencies is probably related to the heterog-
eneous anatomy of the skin; that is, the irregular
distribution of epidermal appendages in the con-
nective tissue of the skin. The glucose disappear-
ance rate constants of blood and skin were deter-
mined for each of the test subjects (Table 1). The
* Milligram per cent glucose excess is defined as
the amount of glucose in excess of the fasting skin
glucose level in mg per cent.
data in Table 1 are insufficient to allow conclu-
sions concerning an inter-relationship of the blood
and skin glucose tolerance tests; but with this
new technic one can determine the rate of disap-
pearance of glucose from human skin. Since a
consistent exponential fall of skin excess glucose
was observed in all our test subjects, it is highly
probable that this first-order kinetic expression
(equation II) will be valid for all individuals.
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